AleAnna Current Ratio 2022-2024 | ANNA

AleAnna current ratio from 2022 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.

AleAnna Current Ratio 2022-2024 | ANNA

AleAnna current ratio from 2022 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$73.2B
Chugai Pharmaceutical (CHGCY)$73B
Takeda Pharmaceutical (TAK)$41.9B
Merck (MKKGY)$18.4B
Sandoz Group AG (SDZNY)$18B
Astellas Pharma (ALPMY)$17.5B
United Therapeutics (UTHR)$16B
Neurocrine Biosciences (NBIX)$13.9B
Summit Therapeutics (SMMT)$13.2B
Shionogi (SGIOY)$11.9B
Madrigal Pharmaceuticals (MDGL)$6.8B
Orion OYJ (ORINY)$6.2B
Ionis Pharmaceuticals (IONS)$5.5B
Corcept Therapeutics (CORT)$5.3B
Crinetics Pharmaceuticals (CRNX)$4.7B
PTC Therapeutics (PTCT)$3.5B
Recursion Pharmaceuticals (RXRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.4B
Dyne Therapeutics (DYN)$2.4B
NewAmsterdam Pharma (NAMS)$2.4B
Centessa Pharmaceuticals (CNTA)$2.2B
Soleno Therapeutics (SLNO)$2B
Indivior (INDV)$1.7B
Xencor (XNCR)$1.7B
BioCryst Pharmaceuticals (BCRX)$1.6B
Evotec AG (EVO)$1.5B
Aurinia Pharmaceuticals Inc (AUPH)$1.3B
Ocular Therapeutix (OCUL)$1.3B
Guardian Pharmacy Services (GRDN)$1.3B